To evaluate whether CD96+ AML cells are enriched for LSC activity, the researchers transplanted CD96+ and CD96− cells AML cells into highly immunodeficient Rag2−/−γc−/− mice. This evidence concerns the gene CD96 and acute myeloid leukemia.